These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8824485)

  • 1. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen.
    Schumacher IK; Newberg MH; Jackson JD; Hammel JM; Rubocki RJ; Engelhard VH; Fox IJ
    Transplantation; 1996 Sep; 62(6):831-6. PubMed ID: 8824485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of gene therapy to induce human-mouse xenogeneic chimerism.
    Fox IJ; Athan E; Fisher J; Baxter T; Podda S; Richardson C
    Surgery; 1993 Aug; 114(2):174-81; discussion 181-2. PubMed ID: 8342123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance by selective in vivo expansion of foreign major histocompatibility complex-transduced autologous bone marrow.
    Zhang JL; Cai J; Walls S; Jackson JD; Kuszynski CA; Zhao Y; Pawliuk R; Leboulch P; Fox IJ
    Transplantation; 2005 Aug; 80(3):362-9. PubMed ID: 16082332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of gene therapy to induce antigen-specific immunologic unresponsiveness to class I xenogeneic major histocompatibility complex antigens.
    Schumacher I; Jeevarathnam S; Rubbocki R; Fox IJ
    Transplant Proc; 1995 Feb; 27(1):313-4. PubMed ID: 7879017
    [No Abstract]   [Full Text] [Related]  

  • 5. Competitive equality of donor cells expressing a disparate MHC antigen following stem cell-enriched bone marrow transplantation.
    Zhang JL; Cai J; Jackson JD; Walls S; Kuszynski CA; Fox IJ
    Transplantation; 2005 May; 79(10):1332-7. PubMed ID: 15912100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
    Clay TM; Custer MC; Spiess PJ; Nishimura MI
    Pathol Oncol Res; 1999; 5(1):3-15. PubMed ID: 10079371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of chimerism in mice using human MHC class I-mismatched Hoechst 33342 side population donor stem cells.
    Jackson JD; Zhou G; Kuszynski CA; Cai J; Fox IJ
    Cell Transplant; 2002; 11(8):779-85. PubMed ID: 12588110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.
    Iglesias MC; Mollier K; Beignon AS; Souque P; Adotevi O; Lemonnier F; Charneau P
    Mol Ther; 2007 Jun; 15(6):1203-10. PubMed ID: 17375069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice.
    Xie Y; Wu J; Xu A; Ahmeqd S; Sami A; Chibbar R; Freywald A; Zheng C; Xiang J
    Vaccine; 2018 Mar; 36(11):1414-1422. PubMed ID: 29415817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of xenogeneic neonatal tolerance to transgenic human leukocyte antigen class I grafts.
    Borenstein SH; Tao KS; Mendicino M; Hu N; West LJ; Chamberlain JW
    Transplantation; 2004 Sep; 78(6):844-52. PubMed ID: 15385803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.
    Aksentijevich I; Sachs DH; Sykes M
    Transplantation; 1992 May; 53(5):1108-14. PubMed ID: 1585475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy.
    Tian C; Bagley J; Iacomini J
    J Immunol; 2002 Oct; 169(7):3771-6. PubMed ID: 12244171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: toward tolerance induction across discordant xenogeneic barriers.
    Chen AM; Zhou Y; Swenson K; Sachs DH; Sykes M; Yang YG
    Transplantation; 2000 Jun; 69(12):2484-90. PubMed ID: 10910267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL.
    Yang S; Linette GP; Longerich S; Roberts BL; Haluska FG
    Cell Immunol; 2000 Aug; 204(1):29-37. PubMed ID: 11006015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.
    Meyer zum Büschenfelde C; Nicklisch N; Rose-John S; Peschel C; Bernhard H
    J Immunol; 2000 Oct; 165(7):4133-40. PubMed ID: 11034426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of porcine MHC DRalpha into IEalpha-deficient murine bone marrow results in reduced IE-restricted Vbeta usage.
    Emery DW; Shimada H; Germana S; Sachs DH; LeGuern C
    Transplantation; 1998 Oct; 66(8):1081-8. PubMed ID: 9808495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
    Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
    Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
    Sharabi Y; Aksentijevich I; Sundt TM; Sachs DH; Sykes M
    J Exp Med; 1990 Jul; 172(1):195-202. PubMed ID: 1972728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant retrovirus vectors for the expression of MHC class II heterodimers.
    Shimada H; Alexander RC; Germana S; Sachs DH; LeGuern C
    Surg Today; 1999; 29(6):533-41. PubMed ID: 10385368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.